Eli Lilly is gearing up to announce its fiscal 2025 fourth-quarter earnings in the near term, and analysts project its ...

Investors with a lot of money to spend have taken a bearish stance on Eli Lilly (NYSE:LLY). And retail traders should know. We noticed this today when the trades showed up on publicly available ...

TrumpRx is supposed to launch in early 2026. Here's what we know about how buying medicine through the site to get discounts on prescription drugs will work ...

Drugmakers plan to raise US prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance, even as President Trump pressures ...

NEW YORK, Dec 31 (Reuters) - Drugmakers plan to raise U.S. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance, even ...

Drugmakers plan to raise U.S. prices on at least 350 branded medications in 2026, including vaccines for COVID-19 and shingles, migraine treatments, and blockbuster cancer drugs, according to data ...

Boehringer Ingelheim has opened another front in its attack on chronic kidney disease (CKD), offering Rectify Pharmaceuticals up to $448 million to partner on a preclinical program. The alliance ...